CD4 and lymphedema: A study showed that upon lymphatic injury, CD4+T cells get activated into a mixed Th1 and Th2 phenotype by dendritic cells in the regional lymph nodes and then migrate to the injury site to initiate lymphedema pharmacological inhibition of T cell release from the lymph nodes.